Evidence map›Paper›PMID 41925801›Full record

ReviewMolecular and cellular biochemistry2026

From copper transport to cuproptosis: emerging therapeutic targets in cardiovascular disease.

Xiaobing Zhang, Jiawen Liu, Cong He, Yu Wang, Qianyue Ni, Yabin Zhou, Jing Sun

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaobing ZhangGraduate School, Heilongjiang University of Chinese Medicine, Harbin, 150000, China.
Jiawen LiuGraduate School, Heilongjiang University of Chinese Medicine, Harbin, 150000, China.
Cong HeGraduate School, Heilongjiang University of Chinese Medicine, Harbin, 150000, China.
Yu WangGraduate School, Heilongjiang University of Chinese Medicine, Harbin, 150000, China.
Qianyue NiGraduate School, Heilongjiang University of Chinese Medicine, Harbin, 150000, China.
Yabin ZhouDepartment of Cardiovascular Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, 150000, China. zhouyabin@hotmail.com.
Jing SunDepartment of Cardiovascular Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, 150000, China. 125045359@qq.com.

Funding

2019 Heilongjiang University of Chinese Medicine Research Fund Project 2019XY04The Seventh Batch of National Famous Old Traditional Chinese Medicine Experts Experience Heritage Construction Program of National Administration of TCM [2022] No. 76
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular diseasesCopperCuproptosisMolecular mechanismTherapeutic strategies

Identifiers

PMID41925801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.